Michael D Luce insider trades: Seracare Life Sciences (SRLS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC






and 50 more companies
Open-market buys and sales
520 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 24, 2009 | SRLS | ↓ Sell | 3,572,569 | $0.27 | $966K | Direct | Feb 25, 2009 (1d) |
| Feb 20, 2009 | SRLS | ↓ Sell | 24,600 | $0.46 | $11K | Direct | Feb 23, 2009 (3d) |
| Feb 18, 2009 | CPN | ↑ Buy | 150,000 | $6.37 | $956K | Direct | Feb 20, 2009 (2d) |
| Feb 18, 2009 | SRLS | ↓ Sell | 29,100 | $0.68 | $20K | Direct | Feb 19, 2009 (1d) |
| Feb 10, 2009 | SRLS | ↓ Sell | 10,500 | $0.95 | $10K | Direct | Feb 12, 2009 (2d) |
| Feb 5, 2009 | SRLS | ↓ Sell | 35,801 | $1.09 | $39K | Direct | Feb 9, 2009 (4d) |
| Feb 4, 2009 | SRLS | ↓ Sell | 60,800 | $0.99 | $60K | Direct | Feb 5, 2009 (1d) |
| Feb 3, 2009 | CLF | ↓ Sell | 1,294,100 | $22.61 | $29.3M | Direct | Feb 4, 2009 (1d) |
| Jan 30, 2009 | SRLS | ↓ Sell | 81,000 | $1.01 | $82K | Direct | Feb 3, 2009 (4d) |
| Jan 30, 2009 | CPN | ↑ Buy | 1,250,594 | $7.29 | $9.1M | Direct | Feb 2, 2009 (3d) |
| Jan 28, 2009 | SRLS | ↓ Sell | 23,000 | $1.07 | $25K | Direct | Jan 30, 2009 (2d) |
| Jan 26, 2009 | SRLS | ↓ Sell | 112,000 | $1.11 | $124K | Direct | Jan 27, 2009 (1d) |
| Jan 22, 2009 | NAV | ↓ Sell | 934,308 | $28.11 | $26.3M | Direct | Jan 22, 2009 (0d) |
| Jan 22, 2009 | SRLS | ↓ Sell | 305,302 | $1.12 | $341K | Direct | Jan 22, 2009 (0d) |
| Jan 16, 2009 | NAV | ↓ Sell | 1,747,400 | $27.28 | $47.7M | Direct | Jan 20, 2009 (4d) |
| Jan 16, 2009 | SRLS | ↓ Sell | 66,700 | $1.35 | $90K | Direct | Jan 20, 2009 (4d) |
| Jan 16, 2009 | CLF | ↓ Sell | 2,898,376 | $22.03 | $63.8M | Direct | Jan 16, 2009 (0d) |
| Jan 14, 2009 | NAV | ↓ Sell | 228,434 | $26.88 | $6.1M | Direct | Jan 15, 2009 (1d) |
| Jan 12, 2009 | CLF | ↓ Sell | 528,912 | $27.62 | $14.6M | Direct | Jan 12, 2009 (0d) |
| Jan 8, 2009 | CLF | ↓ Sell | 1,370,938 | $28.60 | $39.2M | Direct | Jan 9, 2009 (1d) |
| Jan 7, 2009 | NAVZ | ↓ Sell | 500,000 | $30.71 | $15.4M | Direct | Jan 8, 2009 (1d) |
| Dec 26, 2008 | CPN | ↑ Buy | 480,700 | $6.73 | $3.2M | Direct | Dec 30, 2008 (4d) |
| Dec 5, 2008 | MEG | ↓ Sell | 602,778 | $1.53 | $921K | Direct | Dec 9, 2008 (4d) |
| Dec 4, 2008 | MEG | ↓ Sell | 75,978 | $1.60 | $122K | Direct | Dec 5, 2008 (1d) |
| Dec 3, 2008 | PLIAP | ↓ Sell | 72,500 | $0.31 | $22K | Direct | Dec 5, 2008 (2d) |
| Dec 2, 2008 | MEG | ↓ Sell | 184,450 | $1.65 | $304K | Direct | Dec 3, 2008 (1d) |
| Dec 2, 2008 | PLIAP | ↓ Sell | 10,489 | $1.23 | $13K | Direct | Dec 3, 2008 (1d) |
| Nov 26, 2008 | PBSO | ↓ Sell | 3,624,472 | $0.12 | $446K | Direct | Dec 1, 2008 (5d) |
| Nov 26, 2008 | MEG | ↓ Sell | 27,679 | $1.76 | $49K | Direct | Dec 1, 2008 (5d) |
| Nov 26, 2008 | PLIAP | ↓ Sell | 1,600 | $6.53 | $10K | Direct | Dec 1, 2008 (5d) |
| Nov 25, 2008 | MEG | ↓ Sell | 605,489 | $1.60 | $970K | Direct | Nov 26, 2008 (1d) |
| Nov 24, 2008 | PLIAP | ↓ Sell | 7,124 | $0.00 | $7 | Direct | Nov 26, 2008 (2d) |
| Nov 24, 2008 | CPN | ↑ Buy | 700,000 | $7.25 | $5.1M | Direct | Nov 25, 2008 (1d) |
| Nov 21, 2008 | MEG | ↓ Sell | 276,000 | $1.52 | $421K | Direct | Nov 24, 2008 (3d) |
| Nov 21, 2008 | NYT | ↑ Buy | 50,000 | $5.12 | $256K | Direct | Nov 24, 2008 (3d) |
| Nov 20, 2008 | AAWW | ↑ Buy | 16,600 | $9.05 | $150K | Direct | Nov 24, 2008 (4d) |
| Nov 19, 2008 | MEG | ↓ Sell | 282,500 | $3.26 | $920K | Direct | Nov 20, 2008 (1d) |
| Nov 17, 2008 | MEG | ↓ Sell | 103,500 | $4.49 | $464K | Direct | Nov 18, 2008 (1d) |
| Nov 14, 2008 | CPN | ↓ Sell | 223,777 | $8.52 | $1.9M | Direct | Nov 17, 2008 (3d) |
| Nov 13, 2008 | MEG | ↓ Sell | 127,120 | $4.98 | $634K | Direct | Nov 14, 2008 (1d) |
| Nov 12, 2008 | NYT | ↑ Buy | 11,514,246 | $8.38 | $96.5M | Direct | Nov 14, 2008 (2d) |
| Nov 12, 2008 | MIR | ↓ Sell | 4,669,671 | $17.02 | $79.5M | Direct | Nov 14, 2008 (2d) |
| Nov 11, 2008 | MEG | ↓ Sell | 70,150 | $5.82 | $408K | Direct | Nov 12, 2008 (1d) |
| Nov 5, 2008 | MIR | ↓ Sell | 984,756 | $16.75 | $16.5M | Direct | Nov 6, 2008 (1d) |
| Oct 17, 2008 | OC | ↓ Sell | 4,321,799 | $16.50 | $71.3M | Direct | Oct 21, 2008 (4d) |
| Oct 16, 2008 | RTI | ↓ Sell | 282,700 | $13.76 | $3.9M | Direct | Oct 17, 2008 (1d) |
| Oct 15, 2008 | OC | ↓ Sell | 5,879,357 | $16.50 | $97.0M | Direct | Oct 17, 2008 (2d) |
| Oct 15, 2008 | CPN | ↑ Buy | 250,000 | $9.10 | $2.3M | Direct | Oct 17, 2008 (2d) |
| Oct 15, 2008 | GMO | ↓ Sell | 520,016 | $2.11 | $1.1M | Direct | Oct 16, 2008 (1d) |
| Oct 14, 2008 | RTI | ↓ Sell | 231,128 | $16.28 | $3.8M | Direct | Oct 15, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael D Luce's insider trades
Michael D Luce is a 10% owner of Seracare Life Sciences (SRLS). Since May 4, 2005, Michael has reported 383 open-market purchases worth $3.13B and 137 sales worth $1.43B on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (126 filings), grants and awards (9 filings), option exercises (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SRLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.